Ori Spotlight.
The Ori Spotlight podcast covers the latest in cell and gene therapy. Ori CEO Jason C. Foster is joined by leaders from across the industry, to learn more about how we can break down the barriers and seize the opportunities to ensure every patient has access to life-changing treatments.
All Episodes
Ori Spotlight #43 – Aaron Vernon, Quell Therapeutics (part 1 & 2)
Designing scalable cell therapy manufacturing from day one. …
Read more
Ori Spotlight #42 – Amritha Jaishankar, IQVIA
Advancing data integration and decentralized manufacturing for CGT access. …
Read more
Ori Spotlight #41 – Boro Dropulić, Vector Biomed
Simplifying CAR-T workflows will break down barriers to patient access. …
Read more
Ori Spotlight #40 – Michael Krajewski, Stand Back
How does the Theory of Constraints apply to CGT manufacturing? …
Read more
Ori Spotlight #39 – Carl Schoellhammer, DeciBio
Viability is the crucial third pillar in CGT. …
Read more
Ori Spotlight #38 – Anshul Mangal, Project Farma
Unlocking scale, automation, digitalization and standardization in CGT. …
Read more
Ori Spotlight #37 – Omkar Kawalekar, Deloitte
Technology will unlock scalability and patient access. …
Read more
Ori Spotlight #36 – Joe DePinto, McKesson
Bridging growth and accessibility within CGTs. …
Read more
Ori Spotlight #35 – Matthew Hewitt, Charles River Laboratories
Scalability is a collective problem. …
Read more
Ori Spotlight #34 – Adam Siebert and Jeff Holder, LEK Consulting
Early investment in manufacturing is critical for CGT accessibility. …
Read more
Ori Spotlight #33 – Jim Faulkner, JBD BioConsulting
Unaffordable therapy success is worse than failure. …
Read more
Ori Spotlight #32 – Sanjay Srivastava, Accenture’s CGT Practice
Are CGTs developing into a commercial dead-end? …
Read more